Scientific Reports (Oct 2022)

Heterologously secreted MbxA from Moraxella bovis induces a membrane blebbing response of the human host cell

  • Isabelle N. Erenburg,
  • Sebastian Hänsch,
  • Feby M. Chacko,
  • Anna Hamacher,
  • Sebastian Wintgens,
  • Fabian Stuhldreier,
  • Gereon Poschmann,
  • Olivia Spitz,
  • Kai Stühler,
  • Sebastian Wesselborg,
  • Johannes H. Hegemann,
  • Sander H. J. Smits,
  • Stefanie Weidtkamp-Peters,
  • Lutz Schmitt

DOI
https://doi.org/10.1038/s41598-022-22480-x
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 18

Abstract

Read online

Abstract Many proteins of the Repeats in Toxins (RTX) protein family are toxins of Gram-negative pathogens including hemolysin A (HlyA) of uropathogenic E. coli. RTX proteins are secreted via Type I secretion systems (T1SS) and adopt their native conformation in the Ca2+-rich extracellular environment. Here we employed the E. coli HlyA T1SS as a heterologous surrogate system for the RTX toxin MbxA from the bovine pathogen Moraxella bovis. In E. coli the HlyA system successfully activates the heterologous MbxA substrate by acylation and secretes the precursor proMbxA and active MbxA allowing purification of both species in quantities sufficient for a variety of investigations. The activating E. coli acyltransferase HlyC recognizes the acylation sites in MbxA, but unexpectedly in a different acylation pattern as for its endogenous substrate HlyA. HlyC-activated MbxA shows host species-independent activity including a so-far unknown toxicity against human lymphocytes and epithelial cells. Using live-cell imaging, we show an immediate MbxA-mediated permeabilization and a rapidly developing blebbing of the plasma membrane in epithelial cells, which is associated with immediate cell death.